214 related articles for article (PubMed ID: 19299522)
1. Development of a high-throughput brain slice method for studying drug distribution in the central nervous system.
Fridén M; Ducrozet F; Middleton B; Antonsson M; Bredberg U; Hammarlund-Udenaes M
Drug Metab Dispos; 2009 Jun; 37(6):1226-33. PubMed ID: 19299522
[TBL] [Abstract][Full Text] [Related]
2. Addressing central nervous system (CNS) penetration in drug discovery: basics and implications of the evolving new concept.
Reichel A
Chem Biodivers; 2009 Nov; 6(11):2030-49. PubMed ID: 19937839
[TBL] [Abstract][Full Text] [Related]
3. Central nervous system distribution kinetics of indinavir in rats.
Hamidi M
J Pharm Pharmacol; 2007 Aug; 59(8):1077-85. PubMed ID: 17725849
[TBL] [Abstract][Full Text] [Related]
4. Brain tissue binding of drugs: evaluation and validation of solid supported porcine brain membrane vesicles (TRANSIL) as a novel high-throughput method.
Longhi R; Corbioli S; Fontana S; Vinco F; Braggio S; Helmdach L; Schiller J; Boriss H
Drug Metab Dispos; 2011 Feb; 39(2):312-21. PubMed ID: 21071520
[TBL] [Abstract][Full Text] [Related]
5. Measurement of unbound drug exposure in brain: modeling of pH partitioning explains diverging results between the brain slice and brain homogenate methods.
Fridén M; Bergström F; Wan H; Rehngren M; Ahlin G; Hammarlund-Udenaes M; Bredberg U
Drug Metab Dispos; 2011 Mar; 39(3):353-62. PubMed ID: 21149540
[TBL] [Abstract][Full Text] [Related]
6. High-throughput screening of protein binding by equilibrium dialysis combined with liquid chromatography and mass spectrometry.
Wan H; Rehngren M
J Chromatogr A; 2006 Jan; 1102(1-2):125-34. PubMed ID: 16266710
[TBL] [Abstract][Full Text] [Related]
7. Use of a physiologically based pharmacokinetic model to study the time to reach brain equilibrium: an experimental analysis of the role of blood-brain barrier permeability, plasma protein binding, and brain tissue binding.
Liu X; Smith BJ; Chen C; Callegari E; Becker SL; Chen X; Cianfrogna J; Doran AC; Doran SD; Gibbs JP; Hosea N; Liu J; Nelson FR; Szewc MA; Van Deusen J
J Pharmacol Exp Ther; 2005 Jun; 313(3):1254-62. PubMed ID: 15743928
[TBL] [Abstract][Full Text] [Related]
8. High-throughput screening of drug-brain tissue binding and in silico prediction for assessment of central nervous system drug delivery.
Wan H; Rehngren M; Giordanetto F; Bergström F; Tunek A
J Med Chem; 2007 Sep; 50(19):4606-15. PubMed ID: 17725338
[TBL] [Abstract][Full Text] [Related]
9. In vitro methods for estimating unbound drug concentrations in the brain interstitial and intracellular fluids.
Fridén M; Gupta A; Antonsson M; Bredberg U; Hammarlund-Udenaes M
Drug Metab Dispos; 2007 Sep; 35(9):1711-9. PubMed ID: 17591680
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of cerebrospinal fluid concentration and plasma free concentration as a surrogate measurement for brain free concentration.
Liu X; Smith BJ; Chen C; Callegari E; Becker SL; Chen X; Cianfrogna J; Doran AC; Doran SD; Gibbs JP; Hosea N; Liu J; Nelson FR; Szewc MA; Van Deusen J
Drug Metab Dispos; 2006 Sep; 34(9):1443-7. PubMed ID: 16760229
[TBL] [Abstract][Full Text] [Related]
11. High throughput microsomal stability assay for insoluble compounds.
Di L; Kerns EH; Li SQ; Petusky SL
Int J Pharm; 2006 Jul; 317(1):54-60. PubMed ID: 16621364
[TBL] [Abstract][Full Text] [Related]
12. Assessing brain free fraction in early drug discovery.
Read KD; Braggio S
Expert Opin Drug Metab Toxicol; 2010 Mar; 6(3):337-44. PubMed ID: 20102287
[TBL] [Abstract][Full Text] [Related]
13. Studies of drug binding to plasma proteins using a variant of equilibrium dialysis.
Eriksson MA; Gabrielsson J; Nilsson LB
J Pharm Biomed Anal; 2005 Jul; 38(3):381-9. PubMed ID: 15925237
[TBL] [Abstract][Full Text] [Related]
14. Active-site concentrations of chemicals - are they a better predictor of effect than plasma/organ/tissue concentrations?
Hammarlund-Udenaes M
Basic Clin Pharmacol Toxicol; 2010 Mar; 106(3):215-20. PubMed ID: 20050843
[TBL] [Abstract][Full Text] [Related]
15. Unbound drug concentration in brain homogenate and cerebral spinal fluid at steady state as a surrogate for unbound concentration in brain interstitial fluid.
Liu X; Van Natta K; Yeo H; Vilenski O; Weller PE; Worboys PD; Monshouwer M
Drug Metab Dispos; 2009 Apr; 37(4):787-93. PubMed ID: 19116265
[TBL] [Abstract][Full Text] [Related]
16. Strategies to optimize brain penetration in drug discovery.
Liu X; Chen C
Curr Opin Drug Discov Devel; 2005 Jul; 8(4):505-12. PubMed ID: 16022187
[TBL] [Abstract][Full Text] [Related]
17. Utility of whole-body autoradioluminography in drug discovery for the quantification of tritium-labeled drug candidates.
Potchoiba MJ; Nocerini MR
Drug Metab Dispos; 2004 Oct; 32(10):1190-8. PubMed ID: 15377642
[TBL] [Abstract][Full Text] [Related]
18. Utility of unbound plasma drug levels and P-glycoprotein transport data in prediction of central nervous system exposure.
He H; Lyons KA; Shen X; Yao Z; Bleasby K; Chan G; Hafey M; Li X; Xu S; Salituro GM; Cohen LH; Tang W
Xenobiotica; 2009 Sep; 39(9):687-93. PubMed ID: 19569734
[TBL] [Abstract][Full Text] [Related]
19. Rapid screening of blood-brain barrier penetration of drugs using the immobilized artificial membrane phosphatidylcholine column chromatography.
Yoon CH; Kim SJ; Shin BS; Lee KC; Yoo SD
J Biomol Screen; 2006 Feb; 11(1):13-20. PubMed ID: 16314407
[TBL] [Abstract][Full Text] [Related]
20. Central nervous system drug disposition: the relationship between in situ brain permeability and brain free fraction.
Summerfield SG; Read K; Begley DJ; Obradovic T; Hidalgo IJ; Coggon S; Lewis AV; Porter RA; Jeffrey P
J Pharmacol Exp Ther; 2007 Jul; 322(1):205-13. PubMed ID: 17405866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
